Jingxia Jin

机构：The Fourth People's Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University

发表论文 8 篇 · 总被引 72 次 · h-index 5

代表论文

• Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up (2020 · Frontiers in Oncology · 被引 35)
• Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML (2020 · Biomarker Research · 被引 10)
• Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report (2020 · World Journal of Clinical Cases · 被引 10)
• Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma (2018 · Medicine · 被引 5)
• BCOR mutation and TLS-ERG expression in acute myeloid leukemia with monoclonal immunoglobulinemia (2019 · OncoTargets and Therapy · 被引 2)
• Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS (2020 · OncoTargets and Therapy)